Current status of gene therapy for brain tumors
Keywords: Ad, adenoviruses; Ad5, adenovirus serotype 5; CD, cytosine deaminase; CEA, carcinoembryonic antigen; CRAds, conditionally-replicative adenoviruses; 5-FC, 5-fluorocytosine; Flt3L, fms-like tyrosine kinase ligand; GBM, glioblastoma; GCV, ganciclovir; GM-CSF